Literature DB >> 10202376

Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.

D Smith1, G F Watts, C Dane-Stewart, J C Mamo.   

Abstract

BACKGROUND: The clearance of chylomicron remnants was assessed in normolipaemic, dyslipidaemic and obese male subjects by monitoring the plasma kinetics of apolipoprotein (apo) B48, retinyl palmitate and triglyceride after a lipid meal. Regression analysis of fasting plasma apo B48 with the area under the post-prandial curves of apo B48, retinyl ester and triglyceride was carried out in order to determine whether the post-prandial response could be predicted by the fasting concentration of this exclusive chylomicron marker.
MATERIALS AND METHODS: Fasted subjects were given an oral fat load supplemented with retinyl palmitate, and blood samples were drawn over a 10-h period. Apolipoprotein B48 was determined by Western blotting in the plasma density fraction less than 1.063 g mL-1. Plasma retinyl palmitate and triglyceride were determined by high-performance liquid chromatography (HPLC) and colorimetric procedures respectively. The areas under the apo B48, retinyl ester and triglyceride curves were determined by integration. Relationships between the post-prandial response and the fasting concentration of apolipoprotein B48 were assessed using least-squares regression analysis.
RESULTS: We found a strong positive relationship between the fasting plasma concentration of apo B48 and the post-prandial kinetics of apo B48. Similarly, there was a positive relationship of fasting apo B48 with the retinyl ester area under the curve. Collectively, the data suggested that chylomicron remnant kinetics can be predicted based on the fasting level of apo B48. There was also a significant but weaker relationship of fasting apo B48 with post-prandial triglyceride kinetics, consistent with removal of this lipid by hydrolytic mechanisms in addition to particle uptake.
CONCLUSION: The fasting plasma concentration of apo B48 appeared to be a good surrogate marker for the degree of post-prandial lipidaemia and may circumvent the need for oral fat challenges. Moreover, in the fasting state apo B48 concentration is a marker of chylomicron remnants, which are considered to be the proatherogenic form of these intestinally derived lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202376     DOI: 10.1046/j.1365-2362.1999.00431.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  11 in total

1.  Probucol suppresses enterocytic accumulation of amyloid-β induced by saturated fat and cholesterol feeding.

Authors:  Menuka M Pallebage-Gamarallage; Susan Galloway; Ryusuke Takechi; Satvinder Dhaliwal; John C L Mamo
Journal:  Lipids       Date:  2011-07-31       Impact factor: 1.880

Review 2.  Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.

Authors:  D C Chan; J Pang; G Romic; G F Watts
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

3.  A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.

Authors:  Valentin Blanchard; Damien Garçon; Catherine Jaunet; Kevin Chemello; Stéphanie Billon-Crossouard; Audrey Aguesse; Aya Garfa; Gilles Famchon; Amada Torres; Cédric Le May; Matthieu Pichelin; Edith Bigot-Corbel; Gilles Lambert; Bertrand Cariou; Samy Hadjadj; Michel Krempf; Kalyane Bach-Ngohou; Mikaël Croyal
Journal:  J Lipid Res       Date:  2020-05-13       Impact factor: 5.922

4.  Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects.

Authors:  Seiko Otokozawa; Masumi Ai; Margaret R Diffenderfer; Bela F Asztalos; Akira Tanaka; Stefania Lamon-Fava; Ernst J Schaefer
Journal:  Metabolism       Date:  2009-07-09       Impact factor: 8.694

5.  The vascular implications of post-prandial lipoprotein metabolism.

Authors:  David R Sullivan; David S Celermajer; David G Le Couteur; Christopher W K Lam
Journal:  Clin Biochem Rev       Date:  2004-02

6.  Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism.

Authors:  Dick C Chan; Gerald F Watts; Ransi Somaratne; Scott M Wasserman; Rob Scott; P Hugh R Barrett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-06-07       Impact factor: 8.311

7.  Fasting apolipoprotein B48 is associated with large artery atherosclerotic stroke: a case-control study.

Authors:  Jing Tian; Hong Chen; Ping Liu; Chun Wang; Yong Chen
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

8.  Whey Protein Combined with Low Dietary Fiber Improves Lipid Profile in Subjects with Abdominal Obesity: A Randomized, Controlled Trial.

Authors:  Elin Rakvaag; Rasmus Fuglsang-Nielsen; Knud Erik Bach Knudsen; Rikard Landberg; Astrid Johannesson Hjelholt; Esben Søndergaard; Kjeld Hermansen; Søren Gregersen
Journal:  Nutrients       Date:  2019-09-04       Impact factor: 5.717

9.  Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics.

Authors:  E Björnson; C J Packard; M Adiels; L Andersson; N Matikainen; S Söderlund; J Kahri; C Sihlbom; A Thorsell; H Zhou; M-R Taskinen; J Borén
Journal:  J Intern Med       Date:  2019-03-12       Impact factor: 8.989

10.  Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary report.

Authors:  Pedro Valdivielso; José Rioja; Carlota García-Arias; Miguel Angel Sánchez-Chaparro; Pedro González-Santos
Journal:  Cardiovasc Diabetol       Date:  2009-01-08       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.